It has been reported that increased circulating FABP4 levels are associated with obesity, insulin resistance, T2DM, cardiovascular disorders, arterial hypertension, cardiac dysfunction, kidney damage, fatty liver disease, and atherosclerosis [10,29,31,32,39,40,41,42]. This evidence concerns the gene FABP4 and Nephropathy.